STOCK TITAN

VSee Health (VSEE) signs settlement over $271,739.13 secured note

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

VSee Health, Inc. entered into a Settlement Agreement and Mutual Release on July 21, 2026 with ADI Funding LLC and M2B Funding Corp. ADI holds a Secured Promissory Note dated June 8, 2026 with an original principal amount of $271,739.13, issued under earlier transaction documents. ADI had previously sent notice alleging an Event of Default related to obligations tied to an equity line of credit with M2B, including filing a resale Form S-1 and issuing related shares.

The Settlement Agreement resolves all disputes arising from those transactions and provides for cash consideration, Settlement Notes and Settlement Shares for ADI and M2B. An Event of Default under the Settlement Agreement includes failure to make payments, issue the Settlement Notes or Settlement Shares, file a Form 8-K disclosing the agreement, or comply with material covenants. Upon default, all obligations accelerate, unpaid notes accrue 18% interest, conversion rights become immediately exercisable, ADI’s prior rights are reinstated, and the Company must cover related fees and expenses. The mutual release is conditioned on completing the cash payment, issuing the notes and shares, and making the SEC disclosure. The Settlement Notes and Settlement Shares are being issued in private transactions relying on Section 4(a)(2) and/or Regulation D exemptions from Securities Act registration.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Secured note principal $271,739.13 Original principal amount of ADI Secured Promissory Note dated June 8, 2026
Default interest rate 18% Interest rate on all unpaid notes upon an Event of Default under the Settlement Agreement
Common stock par value $0.0001 per share Par value of VSee Health common stock listed on Nasdaq under symbol VSEE
Warrant exercise price $11.50 per share Each VSEEW warrant entitles the holder to purchase one share of common stock at this price
Settlement date July 21, 2026 Date VSee Health entered into the Settlement Agreement and Mutual Release
Prior default notice date June 11, 2026 Date of ADI’s notice alleging an Event of Default under the transaction documents
Settlement Agreement and Mutual Release regulatory
"VSee Health, Inc., a Delaware corporation entered into a Settlement Agreement and Mutual Release"
Secured Promissory Note financial
"ADI is the holder of certain outstanding indebtedness pursuant to a Secured Promissory Note"
A secured promissory note is a written promise to repay borrowed money that is backed by specific assets pledged as collateral; if the borrower fails to pay, the lender can seize those assets to recover losses. Investors care because the collateral reduces the lender’s risk and can make the loan safer and more likely to be repaid, similar to a pawnshop loan where an item lowers the lender’s exposure if the borrower defaults.
Event of Default financial
"notice from ADI alleging an Event of Default occurred under the Existing Transaction Documents"
An event of default is a specific breach of a loan or bond agreement—such as missed payments or breaking agreed rules—that gives lenders the legal right to act, for example by demanding immediate repayment, seizing collateral, or accelerating other obligations. For investors, it’s a red flag because it can sharply reduce a company’s ability to operate or raise money, like a car lender repossessing a vehicle after missed payments, and often leads to falling share or bond prices.
equity line of credit financial
"failure to file a resale registration statement on Form S-1 pursuant to an equity line of credit"
An equity line of credit is a loan that allows homeowners to borrow money against the value of their property, similar to having a flexible credit card secured by their home. It matters to investors because it provides a way for property owners to access cash for various needs, which can influence real estate markets and overall economic activity. This type of credit offers ongoing borrowing capacity, making it a valuable financial tool for those with significant property equity.
Regulation D regulatory
"issued in transactions exempt from registration under Section 4(a)(2) and/or Regulation D"
Regulation D is a set of rules that govern how companies can raise money from investors without going through the full process required for public stock offerings. It provides simplified options for private placements, making it easier for companies to seek investments from a smaller group of investors. For investors, it offers opportunities to invest in private companies, often with fewer restrictions, but also with different levels of risk and disclosure.
Section 4(a)(2) regulatory
"exempt from registration under Section 4(a)(2) of the Securities Act of 1933"
Section 4(a)(2) is a part of U.S. securities laws that allows companies to sell their stock directly to certain investors without registering the sale with regulators. This process is often used for private placements, making it easier and faster for companies to raise money from knowledgeable or institutional investors. It matters to investors because it provides an alternative way to buy shares, often with fewer disclosures and lower costs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What settlement did VSEE Health, Inc. (VSEE) enter into on July 21, 2026?

VSee Health entered a Settlement Agreement and Mutual Release with ADI Funding LLC and M2B Funding Corp. It resolves disputes arising from earlier financing documents, including a secured note and an equity line of credit-related registration and share issuance obligations.

What is the size of the secured promissory note held by ADI in VSEE?

ADI holds a Secured Promissory Note dated June 8, 2026 with an original principal amount of $271,739.13. This note, issued under earlier transaction documents, is central to the disputes that the new Settlement Agreement is designed to resolve among the parties.

What events trigger an Event of Default under VSEE’s new Settlement Agreement?

An Event of Default occurs if VSee Health fails to timely pay under the agreement, issue the Settlement Shares or Settlement Notes, file a Form 8-K describing the settlement, or breaches any material covenant contained in the Settlement Agreement between the parties.

What happens if there is an Event of Default under VSEE’s Settlement Agreement?

If a default occurs, all obligations accelerate, unpaid notes accrue 18% interest, and conversion rights become immediately exercisable. VSee Health must also reimburse reasonable attorneys’ and related fees, and ADI’s rights and remedies under the original transaction documents are fully reinstated.

How are the Settlement Notes and Settlement Shares of VSEE issued under U.S. securities laws?

The Settlement Notes and Settlement Shares are issued in transactions exempt from registration under Section 4(a)(2) of the Securities Act and/or Regulation D, based on the characterization that the offers and sales do not involve a public offering of securities.

How are VSee Health (VSEE) securities listed and what is the warrant exercise price?

VSee Health’s common stock, par value $0.0001 per share, trades on The Nasdaq Stock Market under symbol VSEE. Its warrants trade as VSEEW, each entitling the holder to purchase one share of common stock at an exercise price of $11.50 per whole share.
false 0001864531 0001864531 2026-07-21 2026-07-21 0001864531 VSEE:CommonStock0.0001ParValuePerShareMember 2026-07-21 2026-07-21 0001864531 VSEE:WarrantsWhichEntitlesHolderToPurchaseOne1ShareOfCommonStockAtPriceOf11.50PerWholeShareMember 2026-07-21 2026-07-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 24, 2026 (July 21, 2026)

 

VSEE HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41015   86-2970927
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

980 N Federal Hwy #304
Boca Raton, Florida
  33432
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (561) 672-7068

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class   Trading Symbol   Name of each exchange on
which registered
Common Stock, $0.0001 par value per share   VSEE   The Nasdaq Stock Market LLC
Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share   VSEEW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01Entry into a Material Definitive Agreement.

 

On July 21, 2026, VSee Health, Inc., a Delaware corporation (the “Company”) entered into a Settlement Agreement and Mutual Release (the “Settlement Agreement”) with ADI Funding LLC (“ADI”) and M2B Funding Corp. (“M2B”, together with the Company and ADI, the “Parties”). ADI is the holder of certain outstanding indebtedness of the Company pursuant to a Secured Promissory Note dated June 8, 2026, in the original principal amount of $271,739.13 (the “Existing Note”), issued pursuant to a Securities Purchase Agreement between the Company and ADI, dated June 8, 2026 (the “Existing SPA”), and secured pursuant to a related Security Agreement (the “Existing Security Agreement” and together with the Existing Note and the Existing SPA, the “Transaction Documents”). As previously disclosed, on June 12, 2026, the Company received notice from ADI, dated June 11, 2026, alleging an Event of Default occurred under the Existing Transaction Documents due to the Company’s alleged failure to file a resale registration statement on Form S-1 to register shares for resale pursuant to an equity line of credit (“ELOC”) financing with M2B, failure to file a Form 8-K related to the ELOC and failure to issue transfer agent instructions for the issuance of commitment shares to M2B pursuant to the ELOC, in each case no later than June 11, 2026. The Settlement Agreement resolves all disputes between the Parties regarding the Transaction Documents on the principal terms described herein and in the Settlement Agreement, which is attached as Exhibit 10.1 to this Current Report on Form 8-K.

 

The Settlement Agreement resolves all outstanding disputes among the Parties arising from the Transaction Documents and related transactions. Pursuant to the terms of the Settlement Agreement, in consideration for the mutual promises contained therein, the Company agreed to:

 

repay the Existing Note on the earlier of ninety (90) days following the execution of the Settlement Agreement or immediately upon the Company receiving proceeds from any Financing Transaction (as defined in the Settlement Agreement);

 

apply fifty percent (50%) of all gross process received from any Financing Transaction toward repayment of the Existing Note until the Existing Note has been repaid in full, except for the ELOC, which will pay 100% of proceeds to ADI until repayment of the Existing Note in full;

 

within three (3) business days following execution of the Settlement Agreement, pay ADI $50,000 in cash; if such amount is not received by ADI by the third business day, the unpaid amount shall accrue contractual late charge of five hundred dollars ($500) per day until paid, with no applicable cure period (the “ADI Settlement Cash Consideration”);

 

issue ADI a promissory note in the principal amount of $50,000, which such note shall mature in six (6) months from issuance, will bear no interest prior to maturity, will have no original issue discount and will permit repayment at any time without premium or penalty and, if unpaid at maturity, will accrue interest automatically at eighteen percent (18%) per annum retroactive to the original issuance date; and ADI may convert the outstanding balance into shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company at seventy-five percent (75%) of the lowest VWAP during the twenty (20) trading days immediately preceding conversion (the “ADI Settlement Note”);

 

issue ADI five hundred thousand (500,000) shares of restricted Common Stock with piggyback registration rights (the “ADI Settlement Shares”);

 

issue M2B a promissory note in the principal amount of one hundred and twenty-five thousand dollars ($125,000), with a maturity date of six (6) months after issuance, bearing no interest prior to maturity, having no original issue discount and will permit prepayment without penalty; and, if unpaid at maturity, will accrue interest automatically at eighteen percent (18%) per annum retroactive to the original issuance date; and M2B may convert the outstanding balance into shares of Common Stock of the Company at seventy-five percent (75%) of the lowest VWAP during the twenty (20) trading days immediately preceding conversion (the “M2B Settlement Note” and together with the ADI Settlement Note, the “Settlement Notes”); and

 

issue M2B five hundred thousand (500,000) shares of restricted Common Stock with piggyback registration rights (the “M2B Settlement Shares” and together with the ADI Settlement Shares, the “Settlement Shares”).

 

Each of the following constitutes and Event of Default under the Settlement Agreement: (i) failure to timely make any payment under the Settlement Agreement; (ii) failure to issue the Settlement Shares; (iii) failure to issue the Settlement Notes; (iv) failure to file a Current Report on Form 8-K with the Securities and Exchange Commission (“SEC”) disclosing the material terms of the Settlement Agreement and attaching the Settlement Agreement as an exhibit thereto; and (v) breach of any material covenant in the Settlement Agreement. Upon an Event of Default under the Settlement Agreement, all obligations accelerate immediately, all unpaid notes accrue interest at 18%, conversion rights become immediately exercisable, the Company would be obligated to reimburse all reasonable attorneys’ fees, transfer agent fees, opinion costs and collection expenses and ADI’s rights and remedies under the Transaction Documents would be reinstated and preserved in full.

 

Additionally, the mutual release from liability pursuant to the Settlement Agreement is conditioned upon the payment of the ADI Settlement Cash Consideration, the issuance of the Settlement Notes, the Issuance of the Settlement Shares and the filing of this Form 8-K with the SEC.

 

The foregoing summaries of the Settlement Agreement and the Settlement Notes does not purport to be complete and is qualified in its entirety by reference to the Settlement Agreement, the ADI Settlement Note and the M2B Settlement Note, which will be filed as exhibits to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026.

 

Item 3.02Unregistered Sales of Equity Securities.

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 3.02.

 

The Settlement Notes and Settlement Shares being issued in the connection with the Settlement Agreement were be issued in transactions exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Regulation D promulgated thereunder, because the offer and sale of such securities does not involve a “public offering” as defined in Section 4(a)(2) of the Securities Act, and other applicable requirements were met. Neither this Current Report on Form 8-K nor any of the exhibits attached hereto is an offer to sell or the solicitation of an offer to buy the shares of Common Stock or any other securities of the Company.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 24, 2026 VSEE HEALTH, INC.
     
  By: /s/ Imoigele Aisiku
  Name:  Imoigele Aisiku
  Title: Chief Executive Officer

 

2

 

Filing Exhibits & Attachments

4 documents